Daniel P. Witt is President & VP at REPLIGEN CORP (RGEN). They have made 7 open-market trades across 1 company since 2006, most recently 2014-06-20.
CIK 0001241030
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RGEN | 73,106 | $12.8M |
Shares reported on the most recent Form 4, priced at the 2014-06-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGEN | SELL | 2014-06-06 | 2014-06-09 | $20.56 | $981K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2008-03-04 | 2008-03-06 | $5.42 | $27K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2008-02-20 | 2008-02-22 | $5.80 | $13K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2008-02-14 | 2008-02-19 | $6.28 | $90K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2007-02-28 | 2007-03-02 | $3.10 | $62K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2006-02-17 | 2006-02-22 | $4.25 | $147K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2006-02-14 | 2006-02-16 | $4.25 | $108K | -17.5% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.